Glaucoma laser and surgical procedure rates in Australia

Kerr, Nathan M.; Kumar, H.; Crowston, Jonathan G; Walland, Mark J

doi:10.1136/bjophthalmol-2015-307994

Cited by 22 publications

(29 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A noticeable increase was also observed for aqueous shunts, although the total number remains very low compared with trabeculectomy or deep sclerectomy. These overall trends are very similar to those reported recently in Scotland, England and Wales,15 in Australia16 and in the USA 17…”

Section: Discussionsupporting

confidence: 89%

Trends in operating room-based glaucoma procedures in France from 2005 to 2014: a nationwide study

et al. 2017

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 89%

Trends in operating room-based glaucoma procedures in France from 2005 to 2014: a nationwide study

et al. 2017

View full text Add to dashboard Cite

show abstract

“…New devices and procedures are constantly being developed in an effort to lower intraocular pressure (IOP) in a less invasive and purportedly safe manner. In Australia, there has been a marked increase in MIGS uptake with Medicare data indicating an exponential increase in use over the last few years . Although MIGS is currently seen primarily as adjunct to cataract surgery, it is increasingly being considered as a viable initial treatment option …”

Section: Introductionmentioning

confidence: 99%

“…In Australia, there has been a marked increase in MIGS uptake with Medicare data indicating an exponential increase in use over the last few years. 1,2 Although MIGS is currently seen primarily as adjunct to cataract surgery, it is increasingly being considered as a viable initial treatment option. 3 The objective of this study was to evaluate and compare the first-and second-generation trabecular micro-bypass stents, "iStent" and "iStent inject" (Glaukos Corporation, California).…”

Section: Introductionmentioning

confidence: 99%

Minimally invasive glaucoma surgery: Comparison of iStent with iStent inject in primary open angle glaucoma

Hooshmand¹,

Rothschild

Allen

et al. 2019

Clinical Exper Ophthalmology

View full text Add to dashboard Cite

Importance Minimally invasive glaucoma surgery has gained significant traction in recent years. This study evaluates the first‐ and second‐generation trabecular micro‐bypass stents “iStent” and “iStent inject”. Background To evaluate and compare the effect of a single iStent and double iStent inject in primary open angle glaucoma. Design Prospective comparative case series. Participants Primary open angle glaucoma patients undergoing trabecular micro‐bypass stent insertion combined with cataract surgery. Methods Baseline demographic information, preoperative, intraoperative and postoperative outcomes including intraocular pressure (IOP), visual acuity, reliance on glaucoma medication and complications were collected and analysed. Main Outcome Measures Primary, secondary and tertiary outcome measures were consecutively defined as an IOP of ≤18 mmHg with zero medications, an IOP of ≤18 mmHg with reduced medications or a 20% reduction in IOP with or without medication. Results The study comprised 145 eyes in the iStent and 100 eyes in the iStent inject group. At 12 months, 56.0% of the iStent and 51.3% of the iStent inject eyes had achieved primary success and 63.1% and 57.7% secondary success. The mean postoperative IOP was 16.6 mmHg in iStent and 16.9 mmHg in iStent inject. Survival analysis demonstrated a greater incidence of failure in the iStent inject beyond 5 months. Conclusions and Relevance Both trabecular micro‐bypass stents in this study were effective in reducing IOP and the burden of medication when combined with cataract surgery. There was no statistically significant difference between the two groups across our outcome measures although the iStent inject required earlier recommencement of medications for optimal IOP control.

show abstract

“…Yet, despite the multifactorial causes of glaucoma, lowering intraocular pressure (IOP) has consistently been demonstrated to preserve optic nerve integrity and slow visual field loss . For glaucoma patients with a high IOP that is unresponsive to medication and/or laser, surgical interventions are additional options …”

Section: Introductionmentioning

confidence: 99%

“…3,4 For glaucoma patients with a high IOP that is unresponsive to medication and/or laser, surgical interventions are additional options. [5][6][7] Cyclodestructive techniques, such as endocyclophotocoagulation (ECP), are commonly used treatment options for glaucoma, 8 especially for patients with refractory glaucoma who have failed to respond to routine pharmacological and surgical treatment. 9 These cyclodestructive techniques directly disrupt the ciliary processes that produce aqueous humour, thus decreasing IOP.…”

Section: Introductionmentioning

confidence: 99%

Comparison between pars plana and anterior endoscopic cyclophotocoagulation for the treatment of glaucoma

Feinstein

Lee

Amoozgar

et al. 2019

Clinical Exper Ophthalmology

View full text Add to dashboard Cite

Importance This is the first study to compare the efficacy and safety of endocyclophotocoagulation (ECP) via pars plana (ECP‐plus) with ECP via limbus (anterior ECP) for treating glaucoma. Background There is no direct comparison of treatment outcomes between ECP‐plus and anterior ECP. Design Retrospective study. Participants Fifty‐four consecutive patients. Methods Fifty‐eight eyes from 54 consecutive patients underwent anterior ECP (33 eyes) or ECP‐plus (25 eyes) with 2‐year follow‐up. Linear mixed model was used to analyse the surgical outcomes. Main Outcome Measures Intraocular Pressure (IOP) was the primary outcome. Secondary outcomes were best‐corrected visual acuity, number of glaucoma medications, complications and success rate. Results Compared to anterior ECP, patients in the ECP‐plus group had lower IOP (estimate of effect size [EES] = −3.7 mmHg, P = 0.023) and used fewer number of glaucoma medications (EES = −1.11, P = 0.003), after adjusting for degrees of treatment, preoperative IOP, and presence of combined ECP and phacoemulsification procedure. Patients with ECP‐plus achieved a higher success rate at 2 years postoperatively (80% vs 33.3%, P < 0.001). The decrease in IOP between the preoperative and last follow‐up visit was greater in the ECP‐plus group compared to the anterior ECP group (14.3 mmHg (52%) vs 5.2 mmHg (24%), P = 0.001). There was no significant difference in complication rates between the two groups (28% vs 33%, P = 0.561). Conclusions and Relevance Anterior ECP and ECP‐plus have a similar safety profile, and ECP‐plus may offer superior IOP control for the management of glaucoma.

show abstract

Glaucoma laser and surgical procedure rates in Australia

Cited by 22 publications

References 27 publications

Trends in operating room-based glaucoma procedures in France from 2005 to 2014: a nationwide study

Trends in operating room-based glaucoma procedures in France from 2005 to 2014: a nationwide study

Minimally invasive glaucoma surgery: Comparison of iStent with iStent inject in primary open angle glaucoma

Comparison between pars plana and anterior endoscopic cyclophotocoagulation for the treatment of glaucoma

Contact Info

Product

Resources

About